MassMutual Private Wealth & Trust’s Eagle Pharmaceuticals, Inc. EGRX Stock Holding History

MassMutual Private Wealth & Trust’s Portfolio EGRX Stock Details EGRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-170	Closed	-$891	–	2247
2024 Q1	$891	Buy	+170	New	+$933	﹤0.01%	1733
2023 Q2	–	Sell	-5	Closed	-$142	–	2030
2023 Q1	$142	Buy	+5	New	+$148	﹤0.01%	1778
2022 Q3	–	Sell	-3	Closed	–	–	1853
2022 Q2	$0	Buy	+3	New	+$138	﹤0.01%	1755

Other funds holding EGRX

NCM

Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return

ACM

AIGH Capital Management Baltimore, Maryland $733M AUM 327.32% 1-Year Est. Return

Citigroup New York $235B AUM 32.99% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

MassMutual Private Wealth & Trust's EGRX Position: Q2 2024 in Review

MassMutual Private Wealth & Trust sold out of Eagle Pharmaceuticals, Inc. (EGRX) in Q2 2024, closing a stake of 170 shares — an estimated $891 sold.

MassMutual Private Wealth & Trust first reported a position in EGRX in Q2 2022 and held it in 3 quarters. The position peaked at $891 in Q1 2024. 75 funds tracked by Wall St. Rank hold EGRX as of Q2 2024.

MassMutual Private Wealth & Trust reported no remaining Eagle Pharmaceuticals, Inc. position as of Q2 2024 after selling out during the quarter.
MassMutual Private Wealth & Trust sold 170 Eagle Pharmaceuticals, Inc. shares in Q2 2024, an estimated $891.
MassMutual Private Wealth & Trust first reported a position in Eagle Pharmaceuticals, Inc. in Q2 2022 and held it in 3 quarters.
MassMutual Private Wealth & Trust's Eagle Pharmaceuticals, Inc. position peaked at $891 in Q1 2024.
75 funds tracked by Wall St. Rank held Eagle Pharmaceuticals, Inc. as of Q2 2024.

Based on MassMutual Private Wealth & Trust's 13F filing for Q2 2024, filed 2 Jul 2024.